全部股東
股東類型
- 機構投資者49.46%
- 公眾及其他19.26%
- 私人企業15.84%
- 創投/私募6.76%
- 其他8.68%
主要股東
| 股東 | |||||
|---|---|---|---|---|---|
Clal Life Sciences L.P. | 9.08% | 117.27 萬 | 0.05% | +0 | 30/09/2025 |
Clal Life Sciences L.P. | 9.08% | 117.27 萬 | 0.04% | +0 | 30/09/2025 |
HOLD Fund Management Ltd | 8.06% | 104.00 萬 | 2.57% | +33.65 萬 | 13/02/2026 |
HOLD Fund Management Ltd | 8.06% | 104.00 萬 | 0.04% | +0 | 13/02/2026 |
Mölnlycke Health Care AB | 6.76% | 87.21 萬 | 0.04% | +0 | 30/03/2026 |
Investor AB (publ) | 6.76% | 87.21 萬 | 0.04% | +0 | 31/03/2026 |
Mölnlycke Health Care AB | 6.76% | 87.21 萬 | 0.03% | +0 | 30/03/2026 |
Investor AB (publ) | 6.76% | 87.21 萬 | 0.03% | +0 | 30/06/2026 |
Yelin Lapidot Holdings Ltd. | 5.87% | 75.82 萬 | 0.06% | -4,648.00 | 30/06/2026 |
Yelin Lapidot Holdings Ltd. | 5.87% | 75.82 萬 | 0.06% | -4,648.00 | 30/06/2026 |
Rosalind Advisors, Inc. | 5.80% | 74.91 萬 | 0.03% | +0 | 31/03/2026 |
Rosalind Advisors, Inc. | 5.80% | 74.91 萬 | 0.03% | +0 | 30/06/2026 |
T. Rowe Price Group, Inc. | 5.50% | 70.98 萬 | 1.18% | +15.53 萬 | 31/03/2026 |
T. Rowe Price Group, Inc. | 4.97% | 64.11 萬 | 0.56% | -6.88 萬 | 30/06/2026 |
BlackRock, Inc. | 4.07% | 52.59 萬 | 0.60% | +8.01 萬 | 30/06/2026 |
BlackRock, Inc. | 4.07% | 52.59 萬 | 0.60% | +8.01 萬 | 30/06/2026 |
Israel Biotech Fund | 2.93% | 37.86 萬 | 0.02% | +0 | 16/01/2026 |
Israel Biotech Fund | 2.93% | 37.86 萬 | 0.01% | +0 | 16/01/2026 |
Clal Biotechnology Industries Ltd. | 2.39% | 30.88 萬 | 0.01% | +0 | 30/09/2025 |
Clal Biotechnology Industries Ltd. | 2.39% | 30.88 萬 | 0.01% | +0 | 30/09/2025 |